Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Fozard

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Neuropharmacology|December 1, 1984
Neuronal 5-HT receptors in the peripheryJ R Fozard
Idrugs : the Investigational Drugs Journal|August 2, 2005
BP-294 (Ste Civile Bioprojet)J R Fozard
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
BP-294 Ste Civile BioprojetJ R Fozard
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1995
The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine?J R Fozard
The Journal of Pharmacy and Pharmacology|May 1, 1975
The animal pharmacology of drugs used in the treatment of migraineJ R Fozard
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1984
MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptorsJ R Fozard
Anaesthesia|March 1, 1983
Anaesthesia and familial hypokalaemic periodic paralysisJ R Fozard
Advances in Neurology|January 1, 1982
Basic mechanisms of antimigraine drugsJ R Fozard
European Journal of Pharmacology|March 1, 1976
Comparative effects of four migraine prophylactic drugs on an isolated extracranial arteryJ R Fozard
Journal of Cardiovascular Pharmacology|September 1, 1982
Mechanism of the hypotensive effect of ketanserinJ R Fozard
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Neuropharmacology|December 1, 1984
Neuronal 5-HT receptors in the peripheryJ R Fozard
Idrugs : the Investigational Drugs Journal|August 2, 2005
BP-294 (Ste Civile Bioprojet)J R Fozard
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
BP-294 Ste Civile BioprojetJ R Fozard
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1995
The 5-hydroxytryptamine-nitric oxide connection: the key link in the initiation of migraine?J R Fozard
The Journal of Pharmacy and Pharmacology|May 1, 1975
The animal pharmacology of drugs used in the treatment of migraineJ R Fozard
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1984
MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptorsJ R Fozard
Anaesthesia|March 1, 1983
Anaesthesia and familial hypokalaemic periodic paralysisJ R Fozard
Advances in Neurology|January 1, 1982
Basic mechanisms of antimigraine drugsJ R Fozard
European Journal of Pharmacology|March 1, 1976
Comparative effects of four migraine prophylactic drugs on an isolated extracranial arteryJ R Fozard
Journal of Cardiovascular Pharmacology|September 1, 1982
Mechanism of the hypotensive effect of ketanserinJ R Fozard
Pageof 14